Search results
Results from the WOW.Com Content Network
Aetna began in 1853 in Hartford, CT. CVS Health acquired the company in 2018, and Aetna currently serves the health needs of about 39 million people.. Aetna provides medical, prescription drug ...
An estimated 10,000 New Hampshire seniors got that unsettling message in letters sent out earlier this month by Harvard Pilgrim Health Care, the company that currently covers them under Medicare ...
Utilization management is "a set of techniques used by or on behalf of purchasers of health care benefits to manage health care costs by influencing patient care decision-making through case-by-case assessments of the appropriateness of care prior to its provision," as defined by the Institute of Medicine [1] Committee on Utilization Management by Third Parties (1989; IOM is now the National ...
Harvard Pilgrim is an insurance company that sells Medicare Advantage plans and Medicare supplement (Medigap) plans. It sells these plans to people who live in Massachusetts, Maine, and New Hampshire.
After a request comes in from a qualified provider, the request will go through the prior authorization process. The process to obtain prior authorization varies from insurer to insurer but typically involves the completion and faxing of a prior authorization form; according to a 2018 report, 88% are either partially or entirely manual. [5]
Step therapy, also called step protocol or a fail first requirement, is a managed care approach to prescription.It is a type of prior authorization requirement that is intended increase insurance company profits at the expense of patient health by forcing patients onto lower cost prescription drugs.
Harvard Pilgrim Health Care is a non-profit health services company based in Canton, Massachusetts serving the New England region of the United States. On August 14, 2019, the boards of Harvard Pilgrim Health Care and Tufts Health Plan announced plans for the two insurers to merge their organizations into a new company.
In most countries, a marketing authorisation is valid for a period of 5 years. After this period, one should apply for renewal of the marketing authorisation, usually by providing minimal data proving that quality, efficacy and safety characteristics are maintained and the risk-benefit ratio of the medicinal product is still favourable.